Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Colorectal Neoplasms

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    May 2026
  1. TENTORI L, Leonetti C, Muzi A, Dorio AS, et al
    [Corrigendum] Influence of MLH1 on colon cancer sensitivity to poly(ADP?ribose) polymerase inhibitor combined with irinotecan.
    Int J Oncol. 2026;68:55.
    PubMed     Abstract available


  2. WU S, Wu F, Li X, Jiang Z, et al
    Smoking promotes colorectal cancer via the CKAP2L/AREG axis.
    Int J Oncol. 2026;68:59.
    PubMed     Abstract available


    April 2026
  3. LIN H, Feng J, Chen P, Hu J, et al
    lncRNA AL445238.2?USP4 axis regulates cell survival and stemness in colon cancer.
    Int J Oncol. 2026;68:45.
    PubMed     Abstract available


    February 2026
  4. XIONG B, Ma L, Hu X, Zhang C, et al
    [Retracted] Characterization of side population cells isolated from the colon cancer cell line SW480.
    Int J Oncol. 2026;68:22.
    PubMed     Abstract available


    January 2026
  5. SUN H, Pan Y, He B, Deng Q, et al
    [Expression of Concern] Gene therapy for human colorectal cancer cell lines with recombinant adenovirus 5 based on loss of the insulin?like growth factor 2 imprinting.
    Int J Oncol. 2026;68:7.
    PubMed     Abstract available


    December 2025
  6. FU D, Fu H, Wang Y, Yang K, et al
    Therapeutic potentials of plant?based antioxidants on colorectal cancer: Challenges and perspectives (Review).
    Int J Oncol. 2025;67:107.
    PubMed     Abstract available


    November 2025
  7. COSTABILE V, Duraturo F, Delrio P, Rega D, et al
    [Corrigendum] Lithium chloride induces mesenchymal?to?epithelial reverting transition in primary colon cancer cell cultures.
    Int J Oncol. 2025;67:94.
    PubMed     Abstract available


    August 2025
  8. PAN S, Deng Y, Fu J, Zhang Y, et al
    [Retracted] N6?methyladenosine upregulates miR?181d?5p in exosomes derived from cancer?associated fibroblasts to inhibit 5?FU sensitivity by targeting NCALD in colorectal cancer.
    Int J Oncol. 2025;67:62.
    PubMed     Abstract available


    March 2025
  9. TAN S, Li S, Xia L, Jiang X, et al
    Long non?coding RNA ABHD11?AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway.
    Int J Oncol. 2025;66:20.
    PubMed     Abstract available


  10. YANG Z, Chen Y, Wei X, Wu D, et al
    [Corrigendum] Upregulated NTF4 in colorectal cancer promotes tumor development via regulating autophagy.
    Int J Oncol. 2025;66:19.
    PubMed     Abstract available


  11. JIN Z, Li Y, Yi H, Wang M, et al
    Pathogenetic development, diagnosis and clinical therapeutic approaches for liver metastasis from colorectal cancer (Review).
    Int J Oncol. 2025;66:22.
    PubMed     Abstract available


  12. LI Z, Deng L, Cheng M, Ye X, et al
    Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review).
    Int J Oncol. 2025;66:24.
    PubMed     Abstract available


    February 2025
  13. ZHANG Y, Wang J, Quan R, Lyu L, et al
    circ_0004662 contributes to colorectal cancer progression by interacting with hnRNPM.
    Int J Oncol. 2025;66:14.
    PubMed     Abstract available


    January 2025
  14. PATLOLLA JMR, Zhang Y, Li Q, Steele VE, et al
    [Corrigendum] Anti?carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane?induced colonic aberrant crypt foci formation in rats.
    Int J Oncol. 2025;66:3.
    PubMed     Abstract available


    December 2024
  15. NAKANO Y, Masuda T, Sakamoto T, Tanaka N, et al
    SHARPIN is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression.
    Int J Oncol. 2024;65:113.
    PubMed     Abstract available


    October 2024
  16. LI H, Li D, Meng N
    [Retracted] Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells.
    Int J Oncol. 2024;65:91.
    PubMed     Abstract available


  17. WU K, Wu QX, Yuan SX, Wang DX, et al
    [Corrigendum] The role of IGFBP?5 in mediating the anti?proliferation effect of tetrandrine in human colon cancer cells.
    Int J Oncol. 2024;65:93.
    PubMed     Abstract available


  18. TONG G, Shen Y, Li H, Qian H, et al
    NLRC4, inflammation and colorectal cancer (Review).
    Int J Oncol. 2024;65:99.
    PubMed     Abstract available


    September 2024
  19. ZENG W, Liu H, Mao Y, Jiang S, et al
    Myeloid?derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review).
    Int J Oncol. 2024;65:85.
    PubMed     Abstract available


    June 2024
  20. KIM BR, Kim DY, Tran NL, Kim BG, et al
    Daunorubicin induces GLI1?dependent apoptosis in colorectal cancer cell lines.
    Int J Oncol. 2024;64:66.
    PubMed     Abstract available


    April 2024
  21. KAKAFIKA MG, Lyta AA, Gavriilidis GI, Tsiftsoglou SA, et al
    Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K?562 and colorectal HCT?116 cancer cells.
    Int J Oncol. 2024;64:42.
    PubMed     Abstract available


  22. SUN J, Chen S, Zang D, Sun H, et al
    Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review).
    Int J Oncol. 2024;64:44.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum